Publications

  • Orso F, Virga F, Dettori D, Dalmasso A, Paradzik M, Savino A, Pomatto MAC, Quirico L, Cucinelli S, Coco M, Mareschi K, Fagioli F, Salmena L, Camussi G, Provero P, Poli V, Mazzone M, Pandolfi PP, Taverna D. Stroma-derived miR-214 coordinates tumor dissemination. J Exp Clin Cancer Res. 2023 Jan 13;42(1):20. doi: 10.1186/s13046-022-02553-5. PMID: 36639824; PMCID: PMC9837925. IF: 12.658
  • Dettori* D, Orso* # F, Penna* E, Baruffaldi D, Brundu S, Maione F, Zisoulis DG, Turco E, Giraudo E, Taverna D#. Therapeutic silencing of miR-214 inhibits tumor progression in multiple mouse models, Mol Ther. 2018 Jun 18. pii: S1525-0016(18)30248-X. doi:10.1016/j.ymthe.2018.05.020. [Epub ahead of print] PubMed PMID: 29929788 *these authors contributed equally, # corresponding authors. IF: 11.454
  • Penna E*, Orso F*, Cimino D, Tenaglia E, Lembo A, Quaglino E, Poliseno L, Haimovic A, Osella-Abate S, De Pittà C, Pinatel E, Stadler MB, Provero P, Bernengo MG, Osman I, Taverna D. microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J. 2011 May 18;30(10):1990-2007. Epub 2011 Apr 5. *these authors contributed equally. Comment in Searching for the ‘melano-miRs’: miR-214 drives melanoma metastasis. [EMBO J. 2011]. IF: 11.598.